Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
European Journal of Pharmacology
|
September 21, 1993
Characterization of BIBN 99: a lipophilic and selective muscarinic M2 receptor antagonist
H Doods, M Entzeroth, H Ziegler, et al.
Trends in Pharmacological Sciences
|
December 1, 1989
Structure-activity relationships and pharmacological profile of selective tricyclic antimuscarinics
W G Eberlein, W Engel, G Mihm, et al.
Carcinogenesis
|
April 1, 1986
Binding studies of [3H]lyngbyatoxin A and [3H]debromoaplysiatoxin to the phorbol ester receptor in a mouse epidermal particulate fraction
R E Moore, G M Patterson, M Entzeroth, et al.
Regulatory Peptides
|
August 27, 1996
BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological properties
H N Doods, H A Wieland, W Engel, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1995
Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226
H A Wieland, K D Willim, M Entzeroth, et al.
British Journal of Pharmacology
|
October 1, 1994
Mutations in transmembrane segment VII of the AT1 receptor differentiate between closely related insurmountable and competitive angiotensin antagonists
H T Schambye, B von Wijk, S A Hjorth, et al.
European Journal of Pharmacology
|
May 24, 1995
Labeling of neuropeptide Y receptors in SK-N-MC cells using the novel, nonpeptide Y1 receptor-selective antagonist [3H]BIBP3226
M Entzeroth, H Braunger, W Eberlein, et al.
Journal of Medicinal Chemistry
|
December 10, 1993
6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships
U J Ries, G Mihm, B Narr, et al.
European Journal of Pharmacology
|
December 27, 1994
The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226
K Rudolf, W Eberlein, W Engel, et al.
Life Sciences
|
January 1, 1993
Therapeutic potential of CNS-active M2 antagonists: novel structures and pharmacology
H N Doods, R Quirion, G Mihm, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
European Journal of Pharmacology
|
September 21, 1993
Characterization of BIBN 99: a lipophilic and selective muscarinic M2 receptor antagonist
H Doods, M Entzeroth, H Ziegler, et al.
Trends in Pharmacological Sciences
|
December 1, 1989
Structure-activity relationships and pharmacological profile of selective tricyclic antimuscarinics
W G Eberlein, W Engel, G Mihm, et al.
Carcinogenesis
|
April 1, 1986
Binding studies of [3H]lyngbyatoxin A and [3H]debromoaplysiatoxin to the phorbol ester receptor in a mouse epidermal particulate fraction
R E Moore, G M Patterson, M Entzeroth, et al.
Regulatory Peptides
|
August 27, 1996
BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological properties
H N Doods, H A Wieland, W Engel, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1995
Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226
H A Wieland, K D Willim, M Entzeroth, et al.
British Journal of Pharmacology
|
October 1, 1994
Mutations in transmembrane segment VII of the AT1 receptor differentiate between closely related insurmountable and competitive angiotensin antagonists
H T Schambye, B von Wijk, S A Hjorth, et al.
European Journal of Pharmacology
|
May 24, 1995
Labeling of neuropeptide Y receptors in SK-N-MC cells using the novel, nonpeptide Y1 receptor-selective antagonist [3H]BIBP3226
M Entzeroth, H Braunger, W Eberlein, et al.
Journal of Medicinal Chemistry
|
December 10, 1993
6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships
U J Ries, G Mihm, B Narr, et al.
European Journal of Pharmacology
|
December 27, 1994
The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226
K Rudolf, W Eberlein, W Engel, et al.
Life Sciences
|
January 1, 1993
Therapeutic potential of CNS-active M2 antagonists: novel structures and pharmacology
H N Doods, R Quirion, G Mihm, et al.
Page
of 3